primaquine has been researched along with Co-infection in 5 studies
Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Of late there have been accounts of therapeutic failure and chloroquine resistance in Plasmodium vivax malaria especially from Southeast Asian regions." | 7.81 | Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India. ( Acharya, RV; Acharya, V; Belle, J; Hande, MH; Kamath, A; Rishikesh, K; Saravu, K; Shastry, AB; Vidyasagar, S, 2015) |
| "Of late there have been accounts of therapeutic failure and chloroquine resistance in Plasmodium vivax malaria especially from Southeast Asian regions." | 3.81 | Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India. ( Acharya, RV; Acharya, V; Belle, J; Hande, MH; Kamath, A; Rishikesh, K; Saravu, K; Shastry, AB; Vidyasagar, S, 2015) |
| "The primaquine group had lower 90-day mortality rate (45." | 1.72 | Prognostic factors and clinical efficacy of second-line treatments of Pneumocystis jirovecii pneumonia for non-HIV patients after first-line treatment failure. ( Cao, G; Liu, A; Liu, X; Sun, R; Yang, J; Zhu, H, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, A | 1 |
| Sun, R | 1 |
| Cao, G | 1 |
| Liu, X | 1 |
| Zhu, H | 1 |
| Yang, J | 1 |
| Mansanguan, C | 1 |
| Phumratanaprapin, W | 1 |
| Oki, M | 1 |
| Asai, S | 1 |
| Saito-Nakano, Y | 1 |
| Nakayama, T | 1 |
| Tanaka, Y | 1 |
| Tachibana, H | 1 |
| Ohmae, H | 1 |
| Nozaki, T | 1 |
| Miyachi, H | 1 |
| Rishikesh, K | 1 |
| Kamath, A | 1 |
| Hande, MH | 1 |
| Vidyasagar, S | 1 |
| Acharya, RV | 1 |
| Acharya, V | 1 |
| Belle, J | 1 |
| Shastry, AB | 1 |
| Saravu, K | 1 |
| Markus, MB | 1 |
5 other studies available for primaquine and Co-infection
| Article | Year |
|---|---|
Prognostic factors and clinical efficacy of second-line treatments of Pneumocystis jirovecii pneumonia for non-HIV patients after first-line treatment failure.
Topics: Bacteremia; Clindamycin; Coinfection; Cytomegalovirus Infections; Humans; Pneumocystis carinii; Pneu | 2022 |
Concomitant
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Chloroquine; Coinfection; Female; Fever; Humans; Malari | 2018 |
A case of quadruple malaria infection imported from Mozambique to Japan.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Base Sequence; Coinfe | 2014 |
Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.
Topics: Adolescent; Adult; Aged; Antimalarials; Chloroquine; Coinfection; Drug Therapy, Combination; Female; | 2015 |
Source of clinical malaria in mixed-species infections.
Topics: Artemisinins; Chloroquine; Coinfection; Ethanolamines; Fluorenes; Humans; Malaria; Male; Plasmodium | 2012 |